Sigma Additive Solutions Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Details Narrative)

Stockholders’ Equity (Details Narrative)											1 Months Ended			9 Months Ended		12 Months Ended
Stockholders’ Equity (Details Narrative)	Sep. 30, 2021 USD ($) $ / shares shares	Aug. 11, 2021 $ / shares shares	Jul. 15, 2021 shares	Mar. 31, 2021 USD ($) $ / shares shares	Mar. 26, 2021 $ / shares shares	Feb. 28, 2021 shares	Jan. 31, 2021 USD ($) $ / shares shares	Jan. 08, 2021 shares	Jun. 23, 2020 $ / shares shares	Apr. 06, 2020 USD ($) $ / shares shares	Sep. 30, 2021 USD ($) $ / shares shares	Mar. 31, 2021 $ / shares shares	Jan. 31, 2020 $ / shares shares	Sep. 30, 2021 USD ($) $ / shares shares	Sep. 30, 2020 USD ($) $ / shares shares	Dec. 31, 2020 $ / shares shares	Jun. 30, 2021 shares	May 24, 2021 $ / shares shares
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock, shares authorized	24,000,000										24,000,000			24,000,000		24,000,000	24,000,000	12,000,000
Stock issued during the period					2,190,000		1,711,783
Share price per share \| $ / shares					$ 4.32		$ 3.00
Proceeds from public offering \| $							$ 4,532,445
Term of warrants					2 years		5 years
Warrants exercise price \| $ / shares							$ 3.75
Number of shares, warrants exercised														495,641
Warrants to purchase shares of common stock					2,190,000
Warrants exercisable date					May 24, 2021
Preferred Stock, Shares Authorized	10,000,000										10,000,000			10,000,000	10,000,000	10,000,000
Preferred stock, par value \| $ / shares	$ 0.001										$ 0.001			$ 0.001	$ 0.001	$ 0.001
Preferred stock, shares outstanding	465										465			465	583	715
Preferred stock, shares issued	465										465			465	583	715
Unrecognized share based compensation cost \| $	$ 0										$ 0			$ 0	$ 15,740
Unrecognized deferred compensation expense to be recognized over remainder of year \| $	0										0			$ 0	$ 0
Number of shares granted, description														the Company granted options to purchase a total of 697,831 shares of common stock to 34 employees, 4 directors and 4 consultants with vesting periods ranging from immediately upon issuance to three years beginning January 4, 2021.	the Company granted options to purchase a total of 472,183 shares of common stock to 20 employees, 5 directors and 5 consultants with vesting periods ranging from immediately upon issuance to 3 years beginning July 31, 2020.
Number of shares granted														697,831	472,183	579,998
Share-based Payment Arrangement, Expense \| $														$ 893,431	$ 483,208
Options exercise price \| $ / shares														$ 3.02
Stock options compensation cost \| $	$ 1,544,383										$ 1,544,383			$ 1,544,383
Weighted average remaining recognition period														3 years
Investor [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock issued during the period								100,000
Warrants description								As consideration for the Waiver, the Company issued an additional warrant (“Warrant”) to the Investors to purchase an aggregate of 100,000 shares of common stock, each exercisable after six months for a five-year period with an exercise price equal to 115% of the closing price of the Company’s stock on the date of the waiver.
Dawson James Securities, Inc [Member] \| Placement Agent [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants to purchase shares of common stock										41,237
2013 Equity Incentive Plan [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock issued during the period			1,765,000
Common shares granted for the period											5,204
Common stock shares reserved for issuance			875,000
2013 Stock Option Plan [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock shares reserved for issuance	335,152										335,152			335,152
2020 Stock Appreciation Rights Plan [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Options exercise price \| $ / shares		$ 3.42							$ 2.63
2020 Stock Appreciation Rights Plan [Member] \| President And Chief Executive Officer [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common shares granted for the period		77,748							60,094
2020 Stock Appreciation Rights Plan [Member] \| Vice President [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common shares granted for the period		30,313							12,019
2020 Stock Appreciation Rights Plan [Member] \| Chief Technology Officer [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common shares granted for the period		76,304							24,038
2020 Stock Appreciation Rights Plan [Member] \| Chief Financial Officer [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common shares granted for the period		48,580							18,028
2020 Stock Appreciation Rights Plan [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Unrecognized share based compensation cost \| $	$ 614,947										$ 614,947			$ 614,947
Options exercise price \| $ / shares														$ 3.02
Weighted average remaining recognition period														2 years 10 months 13 days
2021 Stock Appreciated Rights Plan [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Options exercise price \| $ / shares														$ 3.02
CorProminence [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock issued during the period				1,500
Share price per share \| $ / shares				$ 4.99								$ 4.99
April 2020 Offering [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock issued during the period				21,591
Number of shares, warrants exercised				191,204
Placement Agent Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants exercise price \| $ / shares				$ 5.55625								$ 5.55625
Warrants to purchase shares of common stock				175,200								175,200
Placement Agent Warrants [Member] \| Measurement Input, Share Price [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Percentage of warrant exercise price				1.25								1.25
Series D Convertible Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock issued during the period	62,832														3,157,427
Conversion of stock, shares converted															6,109
Preferred stock dividend, shares															749,924
Preferred stock, shares outstanding	132										132			132
Conversion price per share \| $ / shares	$ 2.50										$ 2.50			$ 2.50
Series D Preferred Stock [Member] \| Institutional Securities Purchase Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share issued and sold during period, shares													1,640
Preferred stock, par value \| $ / shares													$ 1,000
Dividends percentage													9.00%
Conversion price per share \| $ / shares													$ 2.50
Conversion description													In addition, a holder may at any time, alternatively, convert all, or any part, of its Series D Preferred Shares at an alternative conversion price, which equals the lower of the applicable conversion price then in effect, and the greater of (x) $1.80 and (y) 85% of the average volume weighted average price (“VWAP”) of the Common Stock for a five (5) trading day period prior to such conversion. Upon the occurrence of certain triggering events, described in the Certificate of Designations, including, but not limited to payment defaults, breaches of transaction documents, failure to maintain listing on the Nasdaq Capital Market, and other defaults set forth therein, the Series D Preferred Shares would become subject to redemption, at the option of a holder, at a 125% premium to the underlying value of the Series D Preferred Shares being redeemed
Series E Convertible Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock issued during the period	61,651
Series E Convertible Preferred Stock [Member] \| Other Securities Purchase Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Conversion of stock, shares converted	48,544
Share issued and sold during period, shares	333
Dividends percentage	9.00%
Private Placement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock issued during the period				119,000		263,200
Private Placement [Member] \| Purchase Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Term of warrants				2 years								2 years
Warrants exercise price \| $ / shares				$ 4.32								$ 4.32
Warrants to purchase shares of common stock				2,190,000								2,190,000
Warrants exercisable date												May 24, 2021
Public Offering [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock issued during the period				2,190,000
Share price per share \| $ / shares				$ 4.445								$ 4.445
Proceeds from public offering \| $				$ 8,736,487						$ 1,230,000
Share issued and sold during period, shares										493,027
Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock issued during the period							136,943
Warrants exercise price \| $ / shares					$ 2.61													$ 2.11
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock issued during the period														3,901,783	493,027
Shares issued for services															25,851
Common Stock [Member] \| Placement Agent Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Percentage of warrant exercise price				0.08								0.08
Common Stock [Member] \| Placement Agent Warrants [Member] \| Measurement Input, Share Price [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Percentage of warrant exercise price				0.080								0.080
Common Stock [Member] \| Series D Convertible Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Conversion of stock, shares converted				250
Number of shares as in-kind payment, shares				19,000
Pre-funded Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants exercise price \| $ / shares										$ 3.64
Warrants to purchase shares of common stock										22,438
Pre-funded Warrants [Member] \| Series A Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants to purchase shares of common stock										515,465
Stock Options [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share-based Payment Arrangement, Expense \| $														$ 874,176	$ 467,468